Kiniksa Pharmaceuticals International, plc (KNSA)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
63. 95
+2.84
+4.6474%
$
4.66B Market Cap
84.4 P/E Ratio
- Div Yield
712,400 Volume
-0.16 Eps
$ 61.11
Previous Close 
Want to track KNSA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kiniksa Pharmaceuticals International, plc (KNSA) Statistics
Valuation metrics
Market Cap 4.66B
Enterprise value 4.63B
Trailing P/E (ttm) 65.26
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 6.38
Price/Book (mrq) 8.08
Enterprise Value/Revenue 6.14
Enterprise Value/EBITDA 42.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 623.82K
Average volume (90 days) 951.98K
Price summary
52-Week low 26.27
52-Week high 67.53
Beta -
50-Day moving average 55.35
200-Day moving average 47.44
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 9.85
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.12
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.79%
Book value per share (mrq) 7.92
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
